Agostini A.; Filippini N.; Cevolani D.; Agati R.; Leoni C.; Tambasco R.; Calabrese C.; Rizzello F.; Gionchetti P.; Ercolani M.; Leonardi M.; Campieri M., Brain functional changes in patients with ulcerative colitis: a functional magnetic resonance imaging study on emotional processing, «INFLAMMATORY BOWEL DISEASES», 2011, 17, pp. 1769 - 1777 [articolo]
Orlando A; Armuzzi A; Papi C; Annese V; Ardizzone S; Biancone L; Bortoli A; Castiglione F; D'Incà R; Gionchetti P; Kohn A; Poggioli G; Rizzello F; Vecchi M; Cottone M., The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in Inflammatory Bowel Disease, «DIGESTIVE AND LIVER DISEASE», 2011, 43, pp. 1 - 20 [articolo]
Lukas M; Drastich P; Konecny M; Gionchetti P; Urban O; Cantoni F; Bortlik M; Duricova D; Bulitta M., Exogenous alkaline phosphatase for the treatment of patients with moderate to severe ulcerative colitis., «INFLAMMATORY BOWEL DISEASES», 2010, 16, pp. 30 - 41 [articolo]
Poggioli G; Laureti S; Pierangeli F; Bazzi P; Coscia M; Gentilini L; Gionchetti P; Rizzello F., Local injection of adalimumab for perianal Crohn's disease: better than infliximab?, «INFLAMMATORY BOWEL DISEASES», 2010, 16, pp. 1631 - 1631 [abstract]
Tambasco R; Gionchetti P; Straforini G; Brugnera R; Spuri Fornarini G; Laureti S; Poggioli G; Campieri M; Rizzello F, OC.01.8 USE OF INFLIXIMAB AND ADALIMUMAB IN REFRACTORY POUCHITIS, in: Abstracts XVI National Congress of Digestive Diseases, Amsterdam, Elsevier Science, «DIGESTIVE AND LIVER DISEASE», 2010, 42, pp. s72 - s72 (atti di: XVI National Congress of Digestive Diseases - Italian Federation of Societies of Digestive Diseases - FISMAD, Verona, 6–9 Marzo 2010) [atti di convegno-abstract]
DE GIORGIO R.; MAZZONI M.; LALATTA-COSTERBOSA G.; CHIOCCHETTI R.; BARBARA G.; BOSI P.; GIONCHETTI P.; RIZZELLO F.; CORINALDESI R.; STANGHELLINI V.; CAMPIERI M.; ROZENGURT E.; STERNINI C.; CLAVENZANI P., A-Transducin, a Signaling Molecule of the Chemoreceptive Cascade, Is Expressed in Endocrine and Non-Endocrine Cells of the Pig Gastrointestinal Mucosa, in: 2008 DDW Abstract Supplement, SAN DIEGO, s.n, «GASTROENTEROLOGY», 2008, Volume 134, Issue 4, Supplement 1, pp. A246 - A246 (atti di: 109th Meeting AGA (American Gastreoenterology Association), Digestive Disease Week, San Diego, USA, May 17 - 22, 2008) [atti di convegno-abstract]
Calabrese C; Gionchetti P; Rizzello F; Liguori G; Gabusi V; Tambasco R; Poggioli G; Pierangeli F; Campieri M; Di Febo G., Short-term treatment with Infliximab in chronic refractory pouchitis and ileitis., «ALIMENTARY PHARMACOLOGY & THERAPEUTICS», 2008, 27, pp. 64 - 759 [articolo]
L. Biancone; P. Gionchetti; G. del V. Blanco; A. Orlando; V. Annese; C. Papi; R. Sostegni; R. D'Inca; C. Petruzziello; A. Casa; G. Sica; E. Calabrese; M. Campieri; F. Pallone., Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study., «DIGESTIVE AND LIVER DISEASE», 2007, 39(4), pp. 329 - 337 [articolo]
Calabrese C; Fabbri A; Gionchetti P; Rizzello F; Morselli C; Liguori G; Poggioli G; Campieri M; Di Febo G, Controlled study using wireless capsule endoscopy for the evaluation of the small intestine in chronic refractory pouchitis, «ALIMENTARY PHARMACOLOGY & THERAPEUTICS», 2007, 25(11), pp. 1311 - 1316 [articolo]
B. Passarini; S.D. Infusino; E. Barbieri; E. Varotti; P. Gionchetti; F. Rizzello; C. Morselli; R. Tambasco; M. Campieri, Cutaneous Manifestations in Inflammatory Bowel Diseases: Eight Cases of Psoriasis Induced by Anti-Tumor-Necrosis-Factor Antibody Therapy, «DERMATOLOGY», 2007, 215, pp. 295 - 300 [articolo]
Gionchetti P.; Rizzello F.; Morselli C.; Poggioli G.; Tambasco R.; Calabrese C.; Brigidi P.; Vitali B.; Straforini G.; Campieri M., High-dose probiotics for the treatment of active pouchitis, «DISEASES OF THE COLON & RECTUM», 2007, 50(12), pp. 2075 - 2082 [articolo]
Poggioli G; Laureti S; Campieri M; Pierangeli F; Gionchetti P; Ugolini F; Gentilini L; Bazzi P; Rizzello F; Coscia M., Infliximab in the treatment of Crohn's disease, «THERAPEUTICS AND CLINICAL RISK MANAGEMENT», 2007, 3, pp. 301 - 308 [articolo]Open Access
M. D’Amato; S. Bruce; F. Bresso; M. Zucchelli; S Ezer; V. Pulkkinen; C. Lindgren; M. Astegiano; M. Rizzetto; P. Gionchetti; G. Riegler; R. Sostegni; M. Daperno; S. D’Alfonso; P. Momigliano–Richiardi; L. Torkvist; P. Puolakkainen; M. Lappalainen; P. Paavola–Sakki ; L. Halme; M. Farkkila; U. Turunen; K. Kontula; R. Lofberg; S. Pettersson; J. Kere, Neuropeptide S Receptor 1 Gene Polymorphism Is Associated With Susceptibility to Inflammatory Bowel Disease, «GASTROENTEROLOGY», 2007, 133, pp. 808 - 817 [articolo]
Gionchetti P.; Rizzello F.; Poggioli G.; Pierangeli F.; Laureti S.; Morselli C.; Tambasco R.; Calabrese C.; Campieri M., Oral budesonide in the treatment of chronic refractory pouchitis., «ALIMENTARY PHARMACOLOGY & THERAPEUTICS», 2007, 25(10), pp. 1231 - 1236 [articolo]
Bresso F.; Askling J.; Astegiano M.; Demarchi B.; Sapone N.; Rizzello M.; Gionchetti P.; Lammers KM.; de Leone A.; Riegler G.; Nimmo ER.; Drummond H.; Noble C.; Torkvist L.; Ekbom A.; Zucchelli M.; Lofberg R.; Satsangi J.; Petterson S.; D'Amato M.;, Potential role for the common cystic fibrosis DeltaF508 mutation in Crohn's disease, «INFLAMMATORY BOWEL DISEASES», 2007, 13, pp. 531 - 536 [articolo]